` FME (Fresenius Medical Care AG) vs DAX Index Comparison - Alpha Spread

FME
vs
DAX Index

Over the past 12 months, FME has outperformed DAX Index, delivering a return of 35% compared to the DAX Index's 31% growth.

Stocks Performance
FME vs DAX Index

Loading
FME
DAX Index
Add Stock
www.alphaspread.com

Performance Gap
FME vs DAX Index

Loading
FME
DAX Index
Difference
www.alphaspread.com

Performance By Year
FME vs DAX Index

Loading
FME
DAX Index
Add Stock

Competitors Performance
Fresenius Medical Care AG vs Peers

Fresenius Medical Care AG
Glance View

Economic Moat
None
Market Cap
28.4B EUR
Industry
Health Care

Fresenius Medical Care AG, a titan in the realm of healthcare, traces its origins back to Germany, where its journey began with an unwavering dedication to improving the lives of individuals suffering from chronic kidney failure. This imperative mission is at the core of its operations, merging compassionate patient care with cutting-edge technologies. As the leading provider of dialysis products and services globally, Fresenius Medical Care operates a vast network of renal care facilities, spanning continents, and serves a diverse patient base. The company designs and manufactures a comprehensive range of dialysis machines and related products, which are crucial to the life-sustaining process of cleansing blood when kidneys fail to function effectively. This seamless integration of service provision and product innovation underpins its success, creating a synergy that sets it apart in the healthcare sector. Revenue streams for Fresenius Medical Care are as diverse as they are robust, stemming from both its product line and its extensive network of clinics. The Clinics Division forms the backbone of its business model by offering treatment options directly to patients through a wide network of dialysis centers. Here, it garners revenue by billing healthcare providers and insurance companies for treatments administered. Meanwhile, its Products Division generates income by catering to both its proprietary clinics and third-party healthcare providers with dialysis equipment, consumables, and accompanying services. This dual-faceted structure ensures a steady flow of income, solidifying its position as an indispensable player in the global chronic kidney disease management landscape and making Fresenius Medical Care a stalwart in healthcare delivery systems worldwide.

FME Intrinsic Value
52.77 EUR
Undervaluation 8%
Intrinsic Value
Price
Back to Top